SCHEMBL30301017

SCHEMBL30301017

CCc1nc(C(=O)NC)c(Cl)nc1NC1CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EML4 Q9HC35 7/20 0.46
ALK Q9UM73 7/20 0.46
AXL P30530 9/20 0.42
ETV6 P41212 6/20 0.42
FLT3 P36888 8/20 0.42
RET P07949 7/20 0.42
ROS1 P08922 7/20 0.42
MAPK1 P28482 2/20 0.38
MAPK3 P27361 1/20 0.38
BRD4 O60885 1/20 0.38
BMPR1B O00238 1/20 0.37
PLK4 O00444 1/20 0.37
CIT O14578 1/20 0.37
AURKA O14965 1/20 0.37
GAK O14976 1/20 0.37
EPHB6 O15197 1/20 0.37
RIPK2 O43353 1/20 0.37
BUB1 O43683 1/20 0.37
SNRNP200 O75643 1/20 0.37
STK16 O75716 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30300959 0.88 EML4 (0.47) EML4ALKAXLETV6FLT3
SCHEMBL30300927 0.86 EML4 (0.56) EML4ALKAXLETV6FLT3
SCHEMBL30300980 0.85 LRRK2 (0.46) EML4ALKAXLETV6FLT3
SCHEMBL31436402 0.74 EML4 (0.56) EML4ALKAXLETV6FLT3
SCHEMBL26702903 0.73 EML4 (0.39) EML4ALKAXLETV6FLT3
SCHEMBL25808963 0.72 SMN1; SMN2 (0.36)
SCHEMBL29944842 0.72 EML4 (0.44) EML4ALKAXLETV6FLT3
SCHEMBL30300861 0.69 AXL (0.64) EML4ALKAXLETV6FLT3
SCHEMBL30151513 0.68 EML4 (0.50) EML4ALKAXLETV6FLT3
SCHEMBL25184619 0.68 MAPK1 (0.39) EML4ALKAXLETV6FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392409-A1 PYRAZINE COMPOUNDS AS IRREVERSIBLE INHIBITORS OF FLT3 Biomea Fusion, Inc. (US) 2024-07-03 EP disclosed
WO-2023027966-A1 PYRAZINE COMPOUNDS AS IRREVERSIBLE INHIBITORS OF FLT3 BIOMEA FUSION, INC. (US) 2023-03-02 WO disclosed